Shell Asset Management’s Ginkgo Bioworks DNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9K | Hold |
843
| – | – | ﹤0.01% | 1253 |
|
2025
Q1 | $5K | Sell |
843
-316
| -27% | -$1.87K | ﹤0.01% | 1253 |
|
2024
Q4 | $11K | Hold |
1,159
| – | – | ﹤0.01% | 1251 |
|
2024
Q3 | $9K | Buy |
+1,159
| New | +$9K | ﹤0.01% | 1247 |
|
2024
Q1 | $9K | Sell |
679
-46
| -6% | -$610 | ﹤0.01% | 1242 |
|
2023
Q4 | $49K | Sell |
725
-217
| -23% | -$14.7K | ﹤0.01% | 1173 |
|
2023
Q3 | $68K | Sell |
942
-15
| -2% | -$1.08K | ﹤0.01% | 1151 |
|
2023
Q2 | $71K | Sell |
957
-6
| -0.6% | -$445 | ﹤0.01% | 1175 |
|
2023
Q1 | $51K | Sell |
963
-3
| -0.3% | -$159 | ﹤0.01% | 1184 |
|
2022
Q4 | $65K | Sell |
966
-181
| -16% | -$12.2K | ﹤0.01% | 1234 |
|
2022
Q3 | $143K | Sell |
1,147
-303
| -21% | -$37.8K | 0.01% | 1125 |
|
2022
Q2 | $138K | Buy |
+1,450
| New | +$138K | ﹤0.01% | 1210 |
|